Cargando…

A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation

Subglottic stenosis represents a challenging clinical condition in otolaryngology. Although patients often experience improvement following endoscopic surgery, recurrence rates remain high. Pursuing measures to maintain surgical results and prevent recurrence is thus necessary. Steroids therapy is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Allon, Raviv, Bhardwaj, Saurabh, Sznitman, Josué, Shoffel-Havakuk, Hagit, Pinhas, Sapir, Zloczower, Elchanan, Shapira-Galitz, Yael, Lahav, Yonatan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056688/
https://www.ncbi.nlm.nih.gov/pubmed/36986764
http://dx.doi.org/10.3390/pharmaceutics15030903
_version_ 1785016185046171648
author Allon, Raviv
Bhardwaj, Saurabh
Sznitman, Josué
Shoffel-Havakuk, Hagit
Pinhas, Sapir
Zloczower, Elchanan
Shapira-Galitz, Yael
Lahav, Yonatan
author_facet Allon, Raviv
Bhardwaj, Saurabh
Sznitman, Josué
Shoffel-Havakuk, Hagit
Pinhas, Sapir
Zloczower, Elchanan
Shapira-Galitz, Yael
Lahav, Yonatan
author_sort Allon, Raviv
collection PubMed
description Subglottic stenosis represents a challenging clinical condition in otolaryngology. Although patients often experience improvement following endoscopic surgery, recurrence rates remain high. Pursuing measures to maintain surgical results and prevent recurrence is thus necessary. Steroids therapy is considered effective in preventing restenosis. Currently, however, the ability of trans-oral steroid inhalation to reach and affect the stenotic subglottic area in a tracheotomized patient is largely negligible. In the present study, we describe a novel trans-tracheostomal retrograde inhalation technique to increase corticosteroid deposition in the subglottic area. We detail our preliminary clinical outcomes in four patients treated with trans-tracheostomal corticosteroid inhalation via a metered dose inhaler (MDI) following surgery. Concurrently, we leverage computational fluid-particle dynamics (CFPD) simulations in an extra-thoracic 3D airway model to gain insight on possible advantages of such a technique over traditional trans-oral inhalation in augmenting aerosol deposition in the stenotic subglottic region. Our numerical simulations show that for an arbitrary inhaled dose (aerosols spanning 1–12 µm), the deposition (mass) fraction in the subglottis is over 30 times higher in the retrograde trans-tracheostomal technique compared to the trans-oral inhalation technique (3.63% vs. 0.11%). Importantly, while a major portion of inhaled aerosols (66.43%) in the trans-oral inhalation maneuver are transported distally past the trachea, the vast majority of aerosols (85.10%) exit through the mouth during trans-tracheostomal inhalation, thereby avoiding undesired deposition in the broader lungs. Overall, the proposed trans-tracheostomal retrograde inhalation technique increases aerosol deposition rates in the subglottis with minor lower-airway deposition compared to the trans-oral inhalation technique. This novel technique could play an important role in preventing restenosis of the subglottis.
format Online
Article
Text
id pubmed-10056688
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100566882023-03-30 A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation Allon, Raviv Bhardwaj, Saurabh Sznitman, Josué Shoffel-Havakuk, Hagit Pinhas, Sapir Zloczower, Elchanan Shapira-Galitz, Yael Lahav, Yonatan Pharmaceutics Article Subglottic stenosis represents a challenging clinical condition in otolaryngology. Although patients often experience improvement following endoscopic surgery, recurrence rates remain high. Pursuing measures to maintain surgical results and prevent recurrence is thus necessary. Steroids therapy is considered effective in preventing restenosis. Currently, however, the ability of trans-oral steroid inhalation to reach and affect the stenotic subglottic area in a tracheotomized patient is largely negligible. In the present study, we describe a novel trans-tracheostomal retrograde inhalation technique to increase corticosteroid deposition in the subglottic area. We detail our preliminary clinical outcomes in four patients treated with trans-tracheostomal corticosteroid inhalation via a metered dose inhaler (MDI) following surgery. Concurrently, we leverage computational fluid-particle dynamics (CFPD) simulations in an extra-thoracic 3D airway model to gain insight on possible advantages of such a technique over traditional trans-oral inhalation in augmenting aerosol deposition in the stenotic subglottic region. Our numerical simulations show that for an arbitrary inhaled dose (aerosols spanning 1–12 µm), the deposition (mass) fraction in the subglottis is over 30 times higher in the retrograde trans-tracheostomal technique compared to the trans-oral inhalation technique (3.63% vs. 0.11%). Importantly, while a major portion of inhaled aerosols (66.43%) in the trans-oral inhalation maneuver are transported distally past the trachea, the vast majority of aerosols (85.10%) exit through the mouth during trans-tracheostomal inhalation, thereby avoiding undesired deposition in the broader lungs. Overall, the proposed trans-tracheostomal retrograde inhalation technique increases aerosol deposition rates in the subglottis with minor lower-airway deposition compared to the trans-oral inhalation technique. This novel technique could play an important role in preventing restenosis of the subglottis. MDPI 2023-03-10 /pmc/articles/PMC10056688/ /pubmed/36986764 http://dx.doi.org/10.3390/pharmaceutics15030903 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Allon, Raviv
Bhardwaj, Saurabh
Sznitman, Josué
Shoffel-Havakuk, Hagit
Pinhas, Sapir
Zloczower, Elchanan
Shapira-Galitz, Yael
Lahav, Yonatan
A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
title A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
title_full A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
title_fullStr A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
title_full_unstemmed A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
title_short A Novel Trans-Tracheostomal Retrograde Inhalation Technique Increases Subglottic Drug Deposition Compared to Traditional Trans-Oral Inhalation
title_sort novel trans-tracheostomal retrograde inhalation technique increases subglottic drug deposition compared to traditional trans-oral inhalation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056688/
https://www.ncbi.nlm.nih.gov/pubmed/36986764
http://dx.doi.org/10.3390/pharmaceutics15030903
work_keys_str_mv AT allonraviv anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT bhardwajsaurabh anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT sznitmanjosue anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT shoffelhavakukhagit anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT pinhassapir anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT zloczowerelchanan anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT shapiragalitzyael anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT lahavyonatan anoveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT allonraviv noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT bhardwajsaurabh noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT sznitmanjosue noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT shoffelhavakukhagit noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT pinhassapir noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT zloczowerelchanan noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT shapiragalitzyael noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation
AT lahavyonatan noveltranstracheostomalretrogradeinhalationtechniqueincreasessubglotticdrugdepositioncomparedtotraditionaltransoralinhalation